Allarity Therapeutics Inc.
ALLR | NASDAQ
$1.19
+$0.02 (+1.71%)
Sep 22, 2026, 2:00 PM ET · Market open
Market Data
Market Cap $18.62M
Enterprise Value $23.92M
Beta 0.56
Average Volume 158.25K
Shares Outstanding (Diluted) 15.91M
Shares Change YoY 2.36%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US0167445008
Price Performance
Price Change 1M -17.6%
Price Change 3M -11.4%
Price Change 6M 4.5%
Price Change YTD 2.6%
Price Change 1Y -34.3%
Price Change 3Y -99.7%
Price Change 5Y -100.0%
1M CAGR (ann.) -15.8%
1Y CAGR (ann.) -25.9%
5Y CAGR (ann.) N/A
All-Time CAGR -96.4%
Valuation
PE Ratio -1.50
Forward PE N/A
PEG Ratio -0.01
Forward PEG -0.20
PS Ratio 53.96
Forward PS 0.20
PB Ratio 5.26
P/FCF Ratio -1.35
P/Adj. FCF Ratio -1.30
P/OCF Ratio -1.36
EV/Sales 69.33
EV/EBIT -2.17
EV/EBITDA -2.16
EV/FCF -1.74
Earnings Yield -66.7%
FCF Yield -74.0%
Adj. FCF Yield -76.9%
Financial Health
Net Debt $5.3M
Total Debt $22.29M
Cash & Short-Term Investments $16.98M
Total Assets $32.12M
Current Ratio 1.11
Quick Ratio 1.11
Debt / Equity Ratio 6.30
Debt / EBITDA -2.01
Debt / FCF -1.62
OCF / Debt -0.62
Interest Coverage -10.15
Altman Z-Score -6.56
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 107.5%
Operating Profit Margin -3129.0%
EBITDA Margin -3213.0%
Net Profit Margin -3575.1%
FCF Margin -3994.8%
Adj. FCF Margin -4147.5%
SBC / Revenue 98.3%
SBC Impact (per share) -3.8%
Returns
Return on Assets -38.4%
Return on Equity -152.8%
Return on Invested Capital -41.8%
Return on Capital Employed -305.3%
Return on Tangible Assets -38.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y -4.5%
EPS CAGR 3Y 149.9%
EPS CAGR 5Y 88.0%
EPS CAGR 10Y 4.5%
FCF CAGR 3Y 6.1%
FCF CAGR 5Y 3.8%
FCF CAGR 10Y -14.3%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.25
EPS Growth Est (next Q) 31.6%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $11
Price Target Upside 840.2%
Cash Flow
Operating Cash Flow $-13.71M
Free Cash Flow $-13.78M
Adj. Free Cash Flow $-14.31M
FCF Per Share -$0.87
OCF Per Share -$0.86
OCF/S Ratio -3973.9%
Income Statement
Revenue $345K
Gross Profit $371K
Operating Income $-10.8M
EBITDA $-11.09M
Net Income $-12.33M
EPS (Diluted) -$0.78
Revenue / Employee $43.13K
Profit / Employee $-1.54M
Employees 8
Add to Watchlist
Select watchlists to add or remove ALLR